SGK
GSK icon

Steigerwald Gordon & Koch’s GSK GSK Stock Holding History

Steigerwald Gordon & Koch’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1K Hold
269
– – ﹤0.01% 489
2026
Q1 		$14.8K Sell
269
-287
-52% -$15.6K ﹤0.01% 473
2025
Q4 		$27.3K Buy
556
+204
+58% +$9.52K ﹤0.01% 405
2025
Q3 		$15.2K Buy
+352
New +$13.8K ﹤0.01% 467

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Steigerwald Gordon & Koch's GSK Position: Q2 2026 in Review

Steigerwald Gordon & Koch held its GSK (GSK) position steady in Q2 2026 at 269 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #489.

Steigerwald Gordon & Koch first reported a position in GSK in Q3 2025 and has held it in 4 quarters since. The position peaked at $27.3K in Q4 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Steigerwald Gordon & Koch held 269 shares of GSK worth $14.1K as of Q2 2026.
  • Steigerwald Gordon & Koch left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #489 holding.
  • Steigerwald Gordon & Koch first reported a position in GSK in Q3 2025 and has held it in 4 quarters since.
  • Steigerwald Gordon & Koch's GSK position peaked at $27.3K in Q4 2025.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.